Latest & greatest articles for cardiovascular disease

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cardiovascular disease or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cardiovascular disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cardiovascular disease

61. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry`s Practice Innovation and Clinical Excellence Registry)

Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (from the National Cardiovascular Disease Registry`s Practice Innovation and Clinical Excellence Registry) Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (From the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence Registry) - PubMed This site needs JavaScript to work properly. Please enable (...) when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions . 2020 May 15;125(10):1500-1507. doi: 10.1016/j.amjcard.2020.02.028. Epub 2020 Mar 5. Comparing Major Bleeding Risk in Outpatients With Atrial Fibrillation or Flutter by Oral Anticoagulant Type (From the National Cardiovascular Disease Registry's Practice Innovation and Clinical

2020 EvidenceUpdates

62. Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis Full Text available with Trip Pro

Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-analysis | medRxiv Search for this keyword Cardiovascular Diseases Burden in COVID-19: Systematic Review and Meta-analysis Amirhossein Hessami , Amir Shamshirian , Keyvan Heydari , Fatemeh Pourali , Reza Alizadeh-Navaei , Mahmood Moosazadeh , Saeed Abrotan , Layla Shojaei , Sogol Sedighi , Danial (...) in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN) , Tehran, Iran 11 Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences , Tehran, Iran 12 Department of Immunology, School of Medicine, Tehran University of Medical Sciences , Tehran, Iran For correspondence: Abstract Background High rate of cardiovascular disease (CVD) have been reported among patients with novel coronavirus disease (COVID-19

2020 Cold Spring Harbor Laboratory

63. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis Full Text available with Trip Pro

Whether cardiovascular disease (CVD) and its traditional risk factors predict severe coronavirus disease 2019 (COVID-19) is uncertain, in part, because of potential confounding by age and sex. Methods We performed a systematic review of studies that explored pre-existing CVD and its traditional risk factors as risk factors of severe COVID-19 (defined as death, acute respiratory distress syndrome, mechanical ventilation, or intensive care unit admission). We searched PubMed and Embase for papers (...) The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis | medRxiv Search for this keyword The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: A systematic review and meta-analysis Kunihiro Matsushita , Ning Ding , Minghao Kou

2020 Cold Spring Harbor Laboratory

64. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Full Text available with Trip Pro

problem of nomenclature that inhibited effective communication became apparent, and this contributed to mistaken diagnoses of POTS. One issue was that even within the expert panel, there was disagreement about whether POTS was a purely cardiovascular and hemodynamic disorder, or one that could be associated with other disorders with systemic (and nonhemodynamic) presentations. Some believed that if a patient had another condition (eg, Ehlers-Danlos syndrome) that they should not be diagnosed with POTS (...) Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance - Canadian Journal of Cardiology Go search , P357-372, March 01, 2020 Powered By Mendeley Share on Canadian Cardiovascular Society Position Statement on Postural Orthostatic

2020 Canadian Cardiovascular Society

65. Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. Full Text available with Trip Pro

Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial. Bromodomain and extraterminal proteins are epigenetic regulators of gene transcription. Apabetalone is a selective bromodomain and extraterminal protein inhibitor targeting bromodomain 2 and is hypothesized to have potentially favorable effects on pathways related to atherothrombosis. Pooled phase 2 data suggest (...) favorable effects on clinical outcomes.To test whether apabetalone significantly reduces major adverse cardiovascular events.A randomized, double-blind, placebo-controlled trial, conducted at 190 sites in 13 countries. Patients with an acute coronary syndrome in the preceding 7 to 90 days, type 2 diabetes, and low high-density lipoprotein cholesterol levels were eligible for enrollment, which started November 11, 2015, and ended July 4, 2018, with end of follow-up on July 3, 2019.Patients were

2020 JAMA

66. Associations of fat and carbohydrate intake with cardiovascular disease and mortality: prospective cohort study of UK Biobank participants. Full Text available with Trip Pro

Associations of fat and carbohydrate intake with cardiovascular disease and mortality: prospective cohort study of UK Biobank participants. To investigate the association of macronutrient intake with all cause mortality and cardiovascular disease (CVD), and the implications for dietary advice.Prospective population based study.UK Biobank.195 658 of the 502 536 participants in UK Biobank completed at least one dietary questionnaire and were included in the analyses. Diet was assessed using

2020 BMJ

67. SAT-064 HYPERPHOSPHATEMIA AS A RISK FACTOR FOR IN-HOSPITAL MORTALITY AMONG PATIENTS WITHOUT OVERT CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS Full Text available with Trip Pro

SAT-064 HYPERPHOSPHATEMIA AS A RISK FACTOR FOR IN-HOSPITAL MORTALITY AMONG PATIENTS WITHOUT OVERT CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS Redirecting

2020 Kidney international reports

68. Gender prevalence of cardiovascular diseases in the geriatric population of India: A meta-analysis using R Full Text available with Trip Pro

[ ] . According to the population census 2011, there are nearly 104 million elderly persons in India which constitutes approximately 8% of the total world population. This share of the population is expected to increase from 8% to nearly 12.6% in 2025 and to 19% in 2050 [ ] . The geriatric population is vulnerable to long-term diseases such as cardiovascular diseases (CVDs), cancer, diabetes, musculoskeletal disorders, depression, arthritis, kidney problems, etc . Due to the increase in life expectancy (...) Gender prevalence of cardiovascular diseases in the geriatric population of India: A meta-analysis using R Gender prevalence of cardiovascular diseases in the geriatric population of India: A meta-analysis using R BPG is committed to discovery and dissemination of knowledge This Article Full Article (HTML) (53) Full Article (PDF) (17) Academic Content and Language Evaluation of This Article CrossCheck and Google Search of This Article Academic Rules and Norms of This Article Citation

2020 World journal of meta-analysis

69. Cardiovascular Disease: Tailored Pharmacy-based Interventions to Improve Medication Adherence

disease prevention medications at least 80% of the time. The proportion of patients considered adherent increased by a median of 6.9 percentage points (an increase of ≈ 9.9%) The remaining 21 studies used various tools to measure adherence (e.g., objective provider counts or records, self-report) and reported generally favorable results. Cardiovascular Disease Risk Conditions A subset of 17 studies evaluated intervention effects on blood pressure control and lipid control. There was a median increase (...) " or "cardiovascular diseases").mp. 33. ("cerebrovascular disease" or "cerebrovascular diseases" or "cerebrovascular event" or "cerebrovascular events" or "angina" or "coronary disease" or "coronary artery disease" or "ischemia" or "myocardial ischemic preconditioning").mp. 34. ("transient ischemic attack" or "brain hypoxia ischemia" or "myocardial ischemia" or "heart diseases" or "myocardial infarction" or "stroke" or "cerebrovascular disorders" or "basal ganglia cerebrovascular disease").mp. 35. (angina pectoris

2020 Community Preventive Services Task Force

70. The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making

The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making 2019 www.kce.fgov.be KCE REPORT 324 THE USE OF STATINS IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: AN ONLINE TOOL FOR SHARED- DECISION MAKING 2019 www.kce.fgov.be KCE REPORT 324 HEALTH TECHNOLOGY ASSESSMENT THE USE OF STATINS IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: AN ONLINE TOOL FOR SHARED-DECISION MAKING CHRISTOPHE DE MEESTER (KCE), KARIN RONDIA (KCE), THOMAS (...) GOORDEN (LEF), SABINE JANSSENS (BSM), PIETER STEYAERT (TEMPERA), CHRIS DE LAET (KCE), MICHEL ALBERTIJN (TEMPERA), LAURENCE KOHN (KCE) COLOPHON Title: The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making Authors: Christophe De Meester (KCE), Karin Rondia (KCE), Thomas Goorden (LEF), Sabine Janssens (BSM), Pieter Steyaert (Tempera), Chris De Laet (KCE), Michel Albertijn (Tempera), Laurence Kohn (KCE) Information specialist: Nicolas Fairon (KCE

2020 Belgian Health Care Knowledge Centre

71. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Full Text available with Trip Pro

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Lipoprotein(a) levels are genetically determined and, when elevated, are a risk factor for cardiovascular disease and aortic stenosis. There are no approved pharmacologic therapies to lower lipoprotein(a) levels.We conducted a randomized, double-blind, placebo-controlled, dose-ranging trial involving 286 patients with established cardiovascular disease and screening lipoprotein(a) levels of at least 60 mg per deciliter (150 nmol (...) 0.003 to <0.001). There were no significant differences between any APO(a)-LRx dose and placebo with respect to platelet counts, liver and renal measures, or influenza-like symptoms. The most common adverse events were injection-site reactions.APO(a)-LRx reduced lipoprotein(a) levels in a dose-dependent manner in patients who had elevated lipoprotein(a) levels and established cardiovascular disease. (Funded by Akcea Therapeutics; ClinicalTrials.gov number, NCT03070782.).Copyright © 2020

2020 NEJM

72. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. Full Text available with Trip Pro

Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study. To examine how a healthy lifestyle is related to life expectancy that is free from major chronic diseases.Prospective cohort study.The Nurses' Health Study (1980-2014; n=73 196) and the Health Professionals Follow-Up Study (1986-2014; n=38 366).Five low risk lifestyle factors: never smoking, body mass index 18.5-24.9, moderate to vigorous physical activity (≥30 minutes (...) /day), moderate alcohol intake (women: 5-15 g/day; men 5-30 g/day), and a higher diet quality score (upper 40%).Life expectancy free of diabetes, cardiovascular diseases, and cancer.The life expectancy free of diabetes, cardiovascular diseases, and cancer at age 50 was 23.7 years (95% confidence interval 22.6 to 24.7) for women who adopted no low risk lifestyle factors, in contrast to 34.4 years (33.1 to 35.5) for women who adopted four or five low risk factors. At age 50, the life expectancy free

2020 BMJ

73. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Full Text available with Trip Pro

. The incidence of acute cardiac injury was about 13 folds higher in ICU/severe patients compared with the non-ICU/severe patients. Conclusion Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the COVID-19. On the other hand, COVID-19 can, in turn, aggravate the damage to the heart. Introduction During the past two decades, the outbreak and prevalence of severe acute (...) of coronaviruses. Trends Microbiol 24:490–502 19. Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181–192 20. Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC (2003) Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 58:686–689 21. Hu S, Gao R, Liu L, Zhu M, Wang W, Wang Y, Wu Z, Li H, Gu D, Yang Y (2019) Summary of the 2018 report on cardiovascular diseases

2020 Covid-19 Ad hoc papers

74. CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic

, and strict measures to limit infection spread within the hospital and to healthcare workers. 1. Risk assessment Downloaded from http://ahajournals.org by on April 10, 202010.1161/CIRCULATIONAHA.120.047011 7 The purpose of risk assessment is to carefully weigh the relative advantages and disadvantages of treating cardiovascular disease all while preventing the risk of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) transmission. During the period of epidemic, under the premise of minimizing (...) CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic 10.1161/CIRCULATIONAHA.120.047011 1 CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic Running Title: Han et al.; Consensus on Managing CVD during COVID-19 Epidemic Yaling Han, MD, FACC, FAHA, Chair 1 ; Hesong Zeng, MD, co-chair 2 ; Hong Jiang, MD, FACC, co

2020 Covid-19 Ad hoc guidelines

75. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic Full Text available with Trip Pro

Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic | JACC: Journal of the American College of Cardiology Advertisement User menu Source Search for this keyword Search Source Search for this keyword Search Journal of the American College of Cardiology DOI: 10.1016/j.jacc (...) .2020.03.031 JACC State-of-the-Art Review Just Accepted Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic Elissa Driggin , Mahesh V. Madhavan , Behnood Bikdeli , Taylor Chuich , Justin Laracy , Giuseppe Bondi-Zoccai , Tyler S. Brown , Caroline Der Nigoghossian , David A. Zidar , Jennifer Haythe , Daniel Brodie , Joshua A. Beckman , Ajay J. Kirtane , Gregg W. Stone , Harlan M. Krumholz and Sahil A. Parikh Author

2020 American College of Cardiology

76. Cardiovascular disease prevention: applying All Our Health

Cardiovascular disease prevention: applying All Our Health Cardiovascular disease prevention: applying All Our Health - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Cardiovascular disease prevention: applying All Our Health Evidence and guidance to help healthcare (...) professionals to prevent heart attacks, strokes and dementia and to improve cardiovascular health. Published 9 January 2019 Last updated 16 December 2019 — From: Documents HTML Details This resource helps: front-line health professionals team leaders or managers senior or strategic leaders to prevent ill health and promote wellbeing as part of their everyday practice. We also recommend important actions that managers and staff holding strategic roles can take. View the full range of topics. Published 9

2020 Public Health England

77. Implementation of interventions to reduce preventable hospital admissions for cardiovascular or respiratory conditions: an evidence map and realist synthesis Full Text available with Trip Pro

Implementation of interventions to reduce preventable hospital admissions for cardiovascular or respiratory conditions: an evidence map and realist synthesis Implementation of interventions to reduce preventable hospital admissions for cardiovascular or respiratory conditions: an evidence map and realist synthesis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found (...) . Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} Factors facilitating implementation of interventions to reduce avoidable admissions for cardiovascular and respiratory conditions can be identified at a patient, general practitioner and health system level. {{author}} {{($index , & . Duncan Chambers * , Anna Cantrell, Andrew Booth School

2020 NIHR HTA programme

78. Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome

Development and validation of a cardiovascular risk score for patients in the community after acute coronary syndrome Development and Validation of a Cardiovascular Risk Score for Patients in the Community After Acute Coronary Syndrome - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) : Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Heart Actions 2019 Dec 10 [Online ahead of print] Development and Validation of a Cardiovascular Risk Score for Patients in the Community After Acute Coronary Syndrome , , , , , , , , Affiliations Expand Affiliations 1 Epidemiology & Biostatistics, University of Auckland, Auckland, New Zealand

2020 EvidenceUpdates

79. Association Between Toothbrushing and Cardiovascular Disease Risk Factors: A Systematic Review Full Text available with Trip Pro

yielded 837 articles. Five eligible articles were from 4 cross-sectional studies and 1 retrospective cohort study conducted in Scotland, Iran, China, and Japan. The cardiovascular disease risk factors examined were behavioral risk factors such as physical activity, drinking, diet, and smoking status; blood pressure, total cholesterol, levels of low-density lipoprotein cholesterol, levels of high-density lipoprotein cholesterol; conditions such as hypertension, hyperuricemia, and dyslipidaemia (...) Association Between Toothbrushing and Cardiovascular Disease Risk Factors: A Systematic Review Association Between Toothbrushing and Cardiovascular Disease Risk Factors: A Systematic Review | Atlantis Press Series: Proceedings of the 2nd Sriwijaya International Conference of Public Health (SICPH 2019) Previous Article In Volume Next Article In Volume Association Between Toothbrushing and Cardiovascular Disease Risk Factors: A Systematic Review Authors Sabrina Intan Zoraya, Abdillah Adipatria

2020 Proceedings of the 2nd Sriwijaya International Conference of Public Health (SICPH 2019)

80. Elevated Osteoprotegerin Concentration Predicts Increased Risk of Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis Full Text available with Trip Pro

in patients with chronic kidney disease (CKD), and these patients have a 10–30 times higher cardiovascular mortality risk than the general population [ ]. In addition to the classic tetrad of smoking, diabetes, dyslipidaemia, and hypertension, mineral and bone metabolism disorders are also identified as risk factors for cardiovascular mortality in patients with CKD [ - ]. Osteoprotegerin (OPG) is a secretory glycoprotein of the TNF receptor superfamily [ ] and has been reported to be involved in bone (...) Elevated Osteoprotegerin Concentration Predicts Increased Risk of Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis Elevated Osteoprotegerin Concentration Predicts Increased Risk of Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis - FullText - Kidney and Blood Pressure Research 2020, Vol. 45, No. 4 - Karger Publishers a " /> b,c " /> b,c " /> d " /> a " /> b,c " /> JavaScript

2020 Kidney and Blood Pressure Research